Back to all papers

The best diagnostic approach for classifying ischemic stroke onset time: A systematic review and meta-analysis.

Authors

Zakariaee SS,Kadir DH,Molazadeh M,Abdi S

Affiliations (4)

  • Ilam University of Medical Sciences, Ilam, Islamic Republic of Iran. [email protected].
  • Salahaddin University-Erbil, Erbil, Iraq.
  • Cihan University-Erbil, Erbil, Iraq.
  • Tabriz University of Medical Sciences, Tabriz, Islamic Republic of Iran.

Abstract

The success of intravenous thrombolysis with tPA (IV-tPA) as the fastest and easiest treatment for stroke patients is closely related to time since stroke onset (TSS). Administering IV-tPA after the recommended time interval (< 4.5 h) increases the risk of cerebral hemorrhage. Despite advances in diagnostic approaches have been made, the determination of TSS remains a clinical challenge. In this study, the performances of different diagnostic approaches were investigated to classify TSS. A systematic literature search was conducted in Web of Science, Pubmed, Scopus, Embase, and Cochrane databases until July 2025. The overall AUC, sensitivity, and specificity magnitudes with their 95%CIs were determined for each diagnostic approach to evaluate their classification performances. This systematic review retrieved a total number of 9030 stroke patients until July 2025. The results showed that the human readings of DWI-FLAIR mismatch as the current gold standard method with AUC = 0.71 (95%CI: 0.66-0.76), sensitivity = 0.62 (95%CI: 0.54-0.71), and specificity = 0.78 (95%CI: 0.72-0.84) has a moderate performance to identify the TSS. ML model fed by radiomic features of CT data with AUC = 0.89 (95%CI: 0.80-0.98), sensitivity = 0.85 (95%CI: 0.75-0.96), and specificity = 0.86 (95%CI: 0.73-1.00) has the best performance in classifying TSS among the models reviewed. ML models fed by radiomic features better classify TSS than the human reading of DWI-FLAIR mismatch. An efficient AI model fed by CT radiomic data could yield the best classification performance to determine patients' eligibility for IV-tPA treatment and improve treatment outcomes.

Topics

Journal ArticleReview

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.